RBBP4 and non-small cell lung carcinoma: Dysregulated expression of RBBP4 is associated with metastasis and unfavorable prognosis in highly aggressive and metastatic cancers, such as non-small cell lung cancer cells (Wang et al., 2021; Cao et al., 2021).